Congenital abnormality of the prothrombin molecule (factor II) in four siblings: prothrombin Barcelona

Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.

Haemophilia : the official journal of the World Federation of Hemophilia·2008

Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development.

Journal of thrombosis and haemostasis : JTH·2007

Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function.

Best practice & research. Clinical haematology·2001

Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.

Thrombosis and haemostasis·2001

Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B.

Blood·2001

Mild haemophilia A discovered in a previously multi-operated 73-year-old man: characterization of a new mutation.

Haemophilia : the official journal of the World Federation of Hemophilia·2001

Neutrophil-dependent interferonopathy contributes to joint damage in hemophilia.

Blood·2026

Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura: final analysis from a randomized phase 3 trial.

Blood·2026

The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

Blood·2026

Rare Hematopoietic Stem Cells resilient to infection-induced stress sense yet withstand inflammation.

Blood·2026

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

Blood·2026

Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).

Blood·2026

Treatment Adherence in Haemophilia: Methods of Assessment, Clinical Outcomes, and Real-World Evidence.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Thrombotic and ischemic event reporting with anticoagulant reversal agents: a multi-agent FAERS pharmacovigilance study.

Journal of thrombosis and thrombolysis·2026

Longitudinal trace element monitoring in haemodialysis patients: Impact of dialysis vintage and technical treatment factors.

Clinical biochemistry·2026

Hand-powered micro-slit-gated microfluidics for concurrent blood typing and hematocrit estimation.

Biosensors & bioelectronics·2026

A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients.

Blood advances·2026

Expanding the spectrum of post-HSCT hemolysis: from passenger lymphocyte syndrome to host- and graft-associated alloimmune hemolytic anemia.

Blood research·2026

Related Experiment Videos

Congenital abnormality of the prothrombin molecule (factor II) in four siblings: prothrombin Barcelona

Related Concept Videos

Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.

Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development.

Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function.

Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.

Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B.

Mild haemophilia A discovered in a previously multi-operated 73-year-old man: characterization of a new mutation.

Neutrophil-dependent interferonopathy contributes to joint damage in hemophilia.

Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura: final analysis from a randomized phase 3 trial.

The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

Rare Hematopoietic Stem Cells resilient to infection-induced stress sense yet withstand inflammation.

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).

Treatment Adherence in Haemophilia: Methods of Assessment, Clinical Outcomes, and Real-World Evidence.

Thrombotic and ischemic event reporting with anticoagulant reversal agents: a multi-agent FAERS pharmacovigilance study.

Longitudinal trace element monitoring in haemodialysis patients: Impact of dialysis vintage and technical treatment factors.

Hand-powered micro-slit-gated microfluidics for concurrent blood typing and hematocrit estimation.

A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients.

Expanding the spectrum of post-HSCT hemolysis: from passenger lymphocyte syndrome to host- and graft-associated alloimmune hemolytic anemia.

Related Experiment Videos

Congenital abnormality of the prothrombin molecule (factor II) in four siblings: prothrombin Barcelona

Related Concept Videos

Related Articles